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Effect of different visual presentations 
on the comprehension of prognostic 
information: a systematic review
Eman Abukmail*, Mina Bakhit, Chris Del Mar and Tammy Hoffmann 
Abstract 
Background: Understanding prognostic information can help patients know what may happen to their health over 
time and make informed decisions. However, communicating prognostic information well can be challenging.
Purpose: To conduct a systematic review to identify and synthesize research that has evaluated visual presentations 
that communicate quantitative prognostic information to patients or the public.
Data sources: MEDLINE, EMBASE, CINAHL, PsycINFO, ERIC and the Cochrane Central Register of Controlled Trials 
(CENTRAL) (from inception to December 2020), and forward and backward citation search.
Study selection: Two authors independently screened search results and assessed eligibility. To be eligible, studies 
required a quantitative design and comparison of at least one visual presentation with another presentation of quan-
titative prognostic information. The primary outcome was comprehension of the presented information. Secondary 
outcomes were preferences for or satisfaction with the presentations viewed, and behavioral intentions.
Data extraction: Two authors independently assessed risk of bias and extracted data.
Data synthesis: Eleven studies (all randomized trials) were identified. We grouped studies according to the presenta-
tion type evaluated. Bar graph versus pictograph (3 studies): no difference in comprehension between the groups. 
Survival vs mortality curves (2 studies): no difference in one study; higher comprehension in survival curve group 
in another study. Tabular format versus pictograph (4 studies): 2 studies reported similar comprehension between 
groups; 2 found higher comprehension in pictograph groups. Tabular versus free text (3 studies): 2 studies found no 
difference between groups; 1 found higher comprehension in a tabular group.
Limitations: Heterogeneity in the visual presentations and outcome measures, precluding meta-analysis.
Conclusions: No visual presentation appears to be consistently superior to communicate quantitative prognostic 
information.
Keywords: Prognosis, Natural history, Health communication, Decision support techniques
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Introduction
Shared decision making is a bidirectional communica-
tion process in which clinicians and patients collaborate 
on making a health decision and discuss the available 
options (based on the best available evidence), the ben-
efits and harms of each option, and the patient’s values, 
preferences, and circumstances [1, 2]. As part of making 
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decisions about the prevention or management of a 
health condition, patients need to know about more than 
just treatment options; they also need to know about the 
prognosis of the condition, with and without treatment.
Communication of prognostic information is essential 
as it helps patients to know what may happen to their 
health over time, to make appropriate preparations, and 
to make informed decisions about whether to intervene 
and if so, how. If prognostic information is not communi-
cated adequately, patients may have inaccurate expecta-
tions about the likely course of their illness [3–5]. Poor 
communication of prognostic information can also make 
patients anxious, confused, and damage the relationship 
between clinician and patient [6, 7].
Prognosis communication can be complex and chal-
lenging for clinicians and patients. Clinicians sometimes 
try to avoid or delay this kind of communication, while 
patients often wait for their clinicians to initiate the pro-
cess [8]. As with the communication of treatment infor-
mation, a contributor to the challenge of communicating 
prognostic information well is the difficulty that clini-
cians and patients can have understanding relevant quan-
titative information [9–11].
To facilitate discussion about prognosis, clinicians may 
use visual means (such as a graph) to present the quan-
titative information. Although there is a large body of 
synthesized evidence on how to communicate the quan-
titative benefits and harms of treatments, we are unaware 
of any synthesis about the various visual presentations 
that can be used to communicate quantitative prognostic 
information.
Methods
The protocol of this systematic review is registered at 
(CRD42020192564) and can be found in the Open Sci-
ence Framework osf.io/ze26g.
Objective
This systematic review aimed to identify and synthesize 
research that has evaluated visual presentations that 
communicate quantitative prognostic information to 
patients or the public.
Information sources
We searched for studies in six databases: MEDLINE, 
EMBASE, CINAHL, ERIC, PsycINFO, and the Cochrane 
Central Register of Controlled Trials (CENTRAL), each 
from date of inception till December 2020. We used a tai-
lored search strategy for each database (see Additional 
file  1). Forward and backward citation analysis of the 
included studies was performed using Web of Science.
Eligibility criteria
Study types and participants
We included only studies with a quantitative design 
that looked at the prognosis of any health condition 
(real condition, hypothetical scenario, or fictitious 
condition). The only participation restriction was the 
exclusion of health professionals or health professional 
students. Studies of mixed populations (e.g. health 
professionals and patients) were eligible if data were 
reported separately for the eligible group. There was no 
limitation on study setting or publication language.
Interventions
Studies were eligible if they compared a visual presen-
tation (e.g. a graph, words and numbers displayed in 
tabular format) with at least one another type of pres-
entation (e.g. another type of graph, or free text) to dis-
play quantitative prognostic information and included 
a specified time frame (e.g. over the next 5  years) or 
time point (e.g. at 1 year). Prognostic information was 
defined as information about the likelihood of any 
future outcome in patients with a given health condi-
tion including those who received no treatment (natu-
ral history) or those who did.
Outcomes
Our primary outcome was comprehension of the pre-
sented information that was assessed using questions 
that required a quantitative answer (e.g. likelihood or 
duration of the outcome). For this reason, only some 
of the questions asked were eligible. Studies/data that 
assessed comprehension with questions requiring qual-
itative responses were ineligible. Secondary outcomes 
included: preferences for any of the presentations eval-
uated; satisfaction with the presentation; and behav-
ioral intentions relevant to the information presented 
(e.g. intention to be screened).
Study selection
Two authors (EA and MB) independently screened the 
titles and abstracts, and then the full text of potentially 
included studies. Discrepancies were resolved through 
consultation with the other two senior authors (CDM 
and TH).
Data extraction and risk of bias assessment
Data were extracted into a custom-designed spread-
sheet. The studies’ characteristics (e.g., study settings, 
sampling methods, study design) and participants’ 
characteristics (e.g., age, sex, educational level, health 
literacy level, numeracy level, and the health condi-
tion studied). Intervention details (including type of 
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presentation (e.g., bar graph), the presented informa-
tion, who delivered the information, how, where and 
when the information was delivered), outcome details 
(including the eligible outcomes, how they were meas-
ured and at what timepoints) and result details (includ-
ing number of responses analysed, follow up rate, 
results of eligible studies) are tabulated in the Addi-
tional file 1 and show the data extracted. Two authors 
(EA and MB) independently extracted relevant data 
and assessed risk of bias of included studies using the 
Cochrane Risk of Bias tool for randomized trials—ver-
sion 2 (RoB2) [12]. Any discrepancies either in data 
extraction or risk of bias assessment were resolved by 
consulting the other two senior authors (CDM and 
TH).
Analysis
Due to heterogeneity of the primary outcome meas-
ures (comprehension) and visual presentations used, we 
were unable to conduct a meta-analysis and therefore 
report the results narratively. The percentage of par-
ticipants who answered each eligible question correctly 
are reported separately for each question and we calcu-
lated the average percentage correct across the eligible 
questions in each study. In studies that did not report 
the percentage correct for an individual question, we 
extracted the overall percentage correct for all compre-
hension questions as reported in the studies.
Modifications from the protocol
After reviewing the articles generated from our search, 
we added explicit exclusion criteria that were not 
detailed in our protocol. Studies that compared alter-
native statistical formats (e.g. relative risk reduction vs. 
absolute risk reduction) and studies that compared the 
framing (i.e. positive or negative) of health information 
were excluded as they have been previously synthesized 
[13, 14]. Also excluded were studies that only compared 
methods of wording free text for conveying prognos-
tic information. The eligibility of the primary outcome 
measure was also clarified to include questions that 
required participants to perform a quantitative calcu-
lation and then select the answer from categorical or 
dichotomous response options. The search strategy 
(see Additional file  1) was slightly modified by adding 
more MeSH terms (e.g., Comprehension, Knowledge, 
Data Display, Communication,  Perception, “Decision 
Making, Shared”) at the request of reviewers during the 




Our search identified 5648 articles across the databases 
and 614 articles identified through forward and back-
ward citation analysis of the included studies (6262 in 
total), 5133 remained after duplicates were removed. 
After the full-text screening, we identified 9 articles: in 
2 of these, 2 separate studies were reported, resulting in 
11 eligible studies [15–23] (Fig. 1).
Characteristics of included studies
All 11 included studies were randomized trials. Seven 
studies were conducted in the United States, 3 in Ger-
many, and 1 in the United Kingdom. The total num-
ber of participants was 9737 (mean 885, range 120 to 
2305). All participants were adults; 4 studies included 
only men, 3 studies included only women, 3 included 
both, and 1 did not report this. Eight studies were con-
ducted online and 3 face-to-face. Health information 
in the interventions related to the prognosis of cancer 
(9 studies), middle ear infection (1 study), and multiple 
sclerosis (1 study). Details of the included studies are 
presented in the Table of characteristics (see Additional 
file 1).
Risk of bias assessment
The overall assessment of the risk of bias of the 11 stud-
ies was judged at “some concerns” level. All included 
articles were judged to have “some concerns” for at 
least one domain of risk of bias. Ten studies had “some 
concerns” for the selection of reported results and six 
had “some concerns” for their randomization process. 
(Fig. 2a, b).
Visual presentations evaluated
Details of the visual presentations evaluated are pro-
vided in the Additional file  1 (Table of interventions). 
Studies were grouped into 4 categories according to 
the presentation type they used: 6 studies compared 
a graphic format to another graphic format: 3 stud-
ies compared a bar graph to a pictograph/icon array, 2 
studies compared survival curves to mortality curves, 
and 1 study compared two variations of pictographs 
(the last is covered in “other comparisons”. Four stud-
ies compared a graphic format to a tabular format (also 
known as a ‘fact box’), Three studies compared a tabu-
lar format to free text. (Fig. 3).
Primary outcome: comprehension
Graph versus graph (6 studies)
Bar graph versus  pictograph (i.e. icon array) (3 stud-
ies) Three studies compared bar graphs to pictographs 
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(see Fig. 4a). There was no statistically significant differ-
ence in comprehension between these types of graphs 
[17, 18, 21]. One of the studies enrolled 420 men and 
randomized them to 1 of 8 graph variations communicat-
ing the likelihood of recurrence of prostate cancer over 
3-time points (including: 3 pictographs and 2 bar graphs 
variations). It found that 89% of participants who viewed 
pictographs (regardless of the variation shown) answered 
comprehension questions correctly compared to 87% of 
those who viewed bar graphs (regardless of the variation 
shown) [17].
In a study on breast cancer prognosis, 1619 partici-
pants were randomized to 1 of 4 graph variations (2 pic-
tographs, 2 bar graphs), 51% of participants who viewed 
pictographs (regardless of the variation) answered com-
prehension questions correctly compared to 42% who 
viewed bar graphs (regardless of the variation) [21]. In 
a study with 682 people with multiple sclerosis, partici-
pants were randomized to 1 of 4 graph variations (2 pic-
tographs, 2  bar graphs). The question about prognosis 
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Fig. 1 PRISMA flow chart of systematic search and selection
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Fig. 2 Risk of bias assessment of the included studies. a: overall, b: individual studies
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pictograph, compared to 64% who viewed the bar graph 
[18].
Survival curves versus mortality curves (2 studies) Two 
studies measured comprehension after presenting par-
ticipants with either survival curves or mortality curves 
(Fig.  4b). A study on the communication of breast can-
cer prognosis analyzed responses of 1461 participants 
and found that there was no difference in comprehension 
regardless of whether a survival or mortality curve was 
presented [22]. A study of 451 participants, using a colon 
cancer scenario, found that those who viewed survival 
curves scored significantly better than those who viewed 
mortality curves, with an average correct difference of 
13%. A group of participants in the same study who were 
shown both survival and mortality curves performed 
slightly better than the group who only saw mortality 
curves, but the difference was not significant [15].
Graph versus tabular format (i.e. fact box) format (4 studies)
Four studies compared pictographs to a tabular for-
mat (Fig. 4c). Two studies (reported in the same article, 
one conducted face-to-face and one online) used three 
groups to compare a  tabular format alone, to a  tabular 
format plus a single pictograph (that showed both ben-
efits and harms), to a tabular format plus two pictographs 
(one showing benefits and one showing harms). In both 
studies, the authors reported that the interventions had 
a similar effect in facilitating comprehension. An aver-
age of 74% of participants who viewed the tabular format 
in the face-to-face study (75% in the online study) com-
pared to 80% who viewed the pictographs (results from 
both pictograph formats combined) (60% in the online 
study) correctly answered comprehension questions [20].
Another article reported two studies: a study commu-
nicating prostate cancer screening information for male 
participants and a study communicating breast cancer 
screening for female participants. The study about pros-
tate cancer found that the use of a pictograph format 
significantly improved comprehension (P = 0.003) com-
pared to a tabular format, with 72% and 61% of partici-
pants answered correctly, respectively. Similar results 
were reported in the breast cancer study, with 62% of 
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Fig. 3 Interventions compared in the included studies. 1A third group received both survival and mortality curve. 2Eight interventions with 
variation of each format type were tested (3 pictographs, 2 bar graphs, 1 line graph, 2 pie graphs). 3Four interventions: 2 static (bar graph, 
pictograph) and 2 animated (bar graph, pictograph). 4Survival curves were delivered either in 5y or 15y worth data and the same for mortality 
curves. 5Four interventions were tested (4-options pictograph, 4-options bar graph, 2-options pictograph, 2-options bar graph). 6Two pictographs; 
a graph with survival only outcome versus a graph with multiple outcomes. 7The three formats were embedded in fact box format, two studies 
were reported one face to face and one online. 8Two conditions were tested in this study; only one contained prognostic information (middle 
ear infection) and was included. 9Two studies were reported (breast cancer screening, female participants) and (prostate cancer screening, male 
participants). Each study tested 3 interventions (pictograph, tabular, free text). X refers to a study group
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the questions correctly compared to 58% who viewed the 
tabular format [19].
Tabular format versus text (3 studies)
Three studies compared a tabular format to a free text 
format (Fig.  4d). Two studies (reported in the same 
article) found no significant difference between using 
a tabular format and free text to communicate prostate 
cancer prognosis to male participants and prognosis 
of breast cancer to female participants. In the prostate 
cancer study, 64% of participants who viewed the text 
format compared to 61% who viewed the tabular format 
answered the questions correctly. In the breast cancer 
study, 61% of those who viewed the text format answered 
correctly compared to 60% of those who viewed tabular 
format [19]. A study communicating prognosis of acute 
middle ear infection with and without antibiotics found 
that participants who saw a tabular format scored sig-
nificantly higher on comprehension questions than those 
who saw a free text format (85% vs 72% correctly answer-
ing) [16].
Other comparisons
Static formats were better understood than animated 
formats when displayed online in a German web-based 
study of 682 people with multiple sclerosis [18]. Dis-
plays that contained less information were generally bet-
ter understood than those with more as found in two 
38
a  Bar graph versus pictograph b  Survival versus mortality curves
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Fig. 4 Comprehension results of visual presentation comparisons (a-d). Graphs are different in each study (see Table of interventions in the 
Additional file 1). Questions are different in each study, for exact wording (see Table of outcomes in the Additional file 1). Kasper 2017 has 1 eligible 
question. Petrova 2015-1 and 2 reported the overall comprehension per format
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studies conducted by the same author [21, 23]. One of 
these found that pictographs with information about 
the outcome of two treatment alternatives, compared to 
those with four, were significantly better understood [21]. 
In the other study, pictographs that presented data for 
only one outcome (survival only; the number of women 
alive after 10 years who had treatment) were significantly 
better understood than pictographs that presented infor-
mation about multiple outcomes (survival, mortality due 
to cancer, mortality due to all causes) [23].
Secondary outcomes
Format preference (1 study)
In the study that randomized participants to 1 of 8 for-
mats (3 pictographs, 2  bar graphs, 1 line graph, 2 pie 
graphs), participants preferred the bar graph and thought 
they would understand it better than other formats. The 
pictograph was rated the lowest on both preference and 
expected understanding, regardless of the format they 
were randomized to. Overall, there was no statistically 
significant difference between graph preference and com-
prehension in this study [17].
Satisfaction (2 studies)
In a study that compared 4 visual presentations (2  bar 
graph variations, 2 pictograph variations), both the pic-
tograph formats (4-options pictograph and 2-options 
pictograph) received statistically significantly higher sat-
isfaction scores compared to the 4-options bar graph. 
However, even though participants were significantly 
more satisfied with the 2-options bar graph compared 
to the 4-options bar graph, the satisfaction scores were 
not as high as for the pictograph formats [21]. In another 
study, a pictograph that contained only survival data had 
significantly higher satisfaction scores than a pictograph 
showing multiple outcomes [23]. Participants of the 
study involving middle ear infection prognostic informa-
tion reported being more engaged with the tabular for-
mat compared to the free text format [16].
Behavioral intentions (4 studies)
Participants in the communication of breast cancer prog-
nosis study who viewed the survival-only pictograph 
were statistically significant less likely to say that they 
would have both chemotherapy and hormonal therapy 
compared to those who viewed the multiple outcome 
pictograph (P = 0.04) [23]. In a 3-arm study that used 
colon cancer information to compare survival curves, 
mortality curves, and both curves, participants who 
viewed survival curves were more likely to choose a pre-
ventive colectomy than an annual exam compared to the 
other two groups [15]. In the study of providing middle 
ear infection prognostic information, the format did not 
affect participants’ recommendation to a family member 
to use antibiotics [16]. Two studies on the communica-
tion of prostate cancer prognosis screening outcomes 
found no association between the type of presentation 
and the intention to be screened for prostate cancer at 
any measurement time point in two studies (one con-
ducted online, one conducted face to face) [20].
Discussion and conclusion
Discussion
Our main finding is that from the existing studies there 
does not appear to be a single type of visual presen-
tation that is consistently superior over another for 
improving the comprehension of quantitative prog-
nostic information for members of the public. In the 
few studies that examined this, simpler formats (such 
as one outcome instead of multiple, and fewer inter-
vention options presented at one time) were generally 
better understood and achieved higher levels of satis-
faction. The impact of various types of visual presenta-
tions on behavioral intention is inconsistent.
Many primary studies and reviews [9, 10, 13, 14, 
24–31], have investigated various methods of commu-
nicating treatment benefits and harms. While there 
are similarities between the communication of treat-
ment benefits and harms and the communication of 
prognosis information, the extent to which methods 
identified as superior for communicating treatment 
quantitative information are also suitable for facilitat-
ing the comprehension of prognosis information is 
unknown. Similar to the findings of a review of meth-
ods of communicating quantitative treatment informa-
tion [9], we found little difference between bar graphs 
and pictographs in facilitating comprehension and that 
there is no superior single method for conveying quan-
titative information.
Research on the comprehension of information from a 
survival curve with different variations found that com-
prehension was generally good across each variation [32]. 
Our review found inconsistent findings of the compara-
tive effect of survival and mortality curves for the com-
prehension of prognosis information. However, we only 
identified two studies that had examined this. Details of 
the chosen curve, such as the complexity of information 
and the time frame used in the curve, maybe as impor-
tant as the type of curve [33–37].
The strengths of our systematic review arise from the 
rigorous method of systematically identifying, screening, 
and reviewing the relevant literature. Our search was not 
limited by language; however, studies that do not have an 
English language title or abstract in the databases might 
have been missed. Although we searched six databases 
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and conducted citation analysis of the included studies, 
we may have missed eligible studies. A meta-analysis was 
precluded due to heterogeneity of the included studies 
as they used many variations of visual presentations and 
comprehension was assessed with different measures. 
Most of the included studies were conducted online, 
using hypothetical scenarios with participants who did 
not have the condition being presented. Studies involv-
ing participants with the condition of interest may gener-
ate different impacts on comprehension, satisfaction, and 
decisions.
Few primary studies have compared the effectiveness 
of different visual presentations on the comprehension 
of quantitative prognostic information and more are 
needed. Most of the existing studies used cancer scenar-
ios and so future research that explores other conditions 
would address this research gap, as would head-to-head 
studies that compare the different presentations. As the 
superiority of any single visual presentation was not 
established in this review, visual presentations should 
be co-designed and piloted with the target population 
before widespread use.
Conclusions
From the existing research, there is inconsistency about 
the superiority of a particular visual presentation to use 
when discussing quantitative prognostic information 
with patients. Any of the existing visual presentations 
that were identified in this review may be suitable to use 
to aid comprehension.
Practice implication
Any of the visual presentations identified may be suit-
able to aid clinicians in discussing prognostic informa-
tion with patients or their carers. More primary research 
is needed to identify how patients or the general public 
understand the prognostic information. Piloting any 
newly developed tool to communicate prognosis with the 
target population is highly recommended.
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